{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:06:23Z","timestamp":1784225183716,"version":"3.55.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T00:00:00Z","timestamp":1519948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.dld.2018.02.011","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T19:37:01Z","timestamp":1519933021000},"page":"429-437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Non-specific gastrointestinal features: Could it be Fabry disease?"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6802-1751","authenticated-orcid":false,"given":"Max J.","family":"Hilz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2948-7994","authenticated-orcid":false,"given":"Eloisa","family":"Arbustini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Dagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Goizet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Politei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Spada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Burlina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2018.02.011_bib0005","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.2174\/13816128113199990347","article-title":"Gastroenterological complications of Anderson\u2013Fabry disease","volume":"19","author":"Buda","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.dld.2018.02.011_bib0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.dld.2018.02.011_bib0015","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/08035250500275022","article-title":"Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey","volume":"95","author":"Ramaswami","year":"2006","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.dld.2018.02.011_bib0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/jmg.2005.036327","article-title":"Natural history of Fabry disease in females in the Fabry Outcome Survey","volume":"43","author":"Deegan","year":"2018","journal-title":"J Med Genet"},{"key":"10.1016\/j.dld.2018.02.011_bib0025","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.cgh.2007.08.012","article-title":"Gastrointestinal symptoms in 342 patients with Fabry disease: prevalence and response to enzyme replacement therapy","volume":"5","author":"Hoffmann","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2018.02.011_bib0030","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1203\/PDR.0b013e318183f132","article-title":"Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry","volume":"64","author":"Hopkin","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1016\/j.dld.2018.02.011_bib0035","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ymgme.2011.03.022","article-title":"Response of women with Fabry disease to enzyme replacement therapy: comparison with men, using data from FOS\u2014the Fabry Outcome Survey","volume":"103","author":"Hughes","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.dld.2018.02.011_bib0040","doi-asserted-by":"crossref","first-page":"9712831","DOI":"10.1155\/2016\/9712831","article-title":"Gastrointestinal symptoms of patients with Fabry disease","volume":"2016","author":"Pensabene","year":"2016","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.dld.2018.02.011_bib0045","doi-asserted-by":"crossref","DOI":"10.1007\/8904_2017_28","article-title":"Improvement of Fabry disease-related gastrointestinal symptoms in a significant proportion of female patients treated with agalsidase beta: data from the Fabry Registry","author":"Wilcox","year":"2017","journal-title":"JIMD Rep"},{"key":"10.1016\/j.dld.2018.02.011_bib0050","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson\u2013Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.dld.2018.02.011_bib0055","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","article-title":"Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry","volume":"30","author":"Eng","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.dld.2018.02.011_bib0060","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1399-0004.2011.01671.x","article-title":"Fabry disease in children and response to enzyme replacement therapy: results from the Fabry Outcome Survey","volume":"81","author":"Ramaswami","year":"2012","journal-title":"Clin Genet"},{"key":"10.1016\/j.dld.2018.02.011_bib0065","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jmedgenet-2014-102797","article-title":"Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease","volume":"52","author":"Germain","year":"2015","journal-title":"J Med Genet"},{"key":"10.1016\/j.dld.2018.02.011_bib0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13023-015-0338-2","article-title":"Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years\u2019 treatment","volume":"10","author":"Kampmann","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.dld.2018.02.011_bib0075","doi-asserted-by":"crossref","first-page":"107558","DOI":"10.18632\/oncotarget.22505","article-title":"Genetic variants associated with Fabry disease progression despite enzyme replacement therapy","volume":"8","author":"Scionti","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.dld.2018.02.011_bib0080","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1510198","article-title":"Treatment of Fabry's disease with the pharmacologic chaperone migalastat","volume":"375","author":"Germain","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2018.02.011_bib0085","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","article-title":"Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry","volume":"93","author":"Wilcox","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.dld.2018.02.011_bib0090","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jpeds.2010.02.012","article-title":"Misdiagnosis in Fabry disease","volume":"156","author":"Marchesoni","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.dld.2018.02.011_bib0095","doi-asserted-by":"crossref","first-page":"e0124987","DOI":"10.1371\/journal.pone.0124987","article-title":"Characterization of early disease status in treatment-naive male paediatric patients with Fabry disease enrolled in a randomized clinical trial","volume":"10","author":"Wijburg","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2018.02.011_bib0100","doi-asserted-by":"crossref","first-page":"e36373","DOI":"10.1371\/journal.pone.0036373","article-title":"Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease","volume":"7","author":"Namdar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2018.02.011_bib0105","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00004691-200212000-00011","article-title":"Small fiber dysfunction predominates in Fabry neuropathy","volume":"19","author":"D\u00fctsch","year":"2002","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.dld.2018.02.011_bib0110","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/ndt\/gfp031","article-title":"Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy","volume":"24","author":"Schiffmann","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.dld.2018.02.011_bib0115","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/STROKEAHA.114.006283","article-title":"Cerebrovascular involvement in Fabry disease: current status of knowledge","volume":"46","author":"Kolodny","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.dld.2018.02.011_bib0120","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/GIM.0b013e3181bb05bb","article-title":"Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry","volume":"11","author":"Waldek","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.dld.2018.02.011_bib0125","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.gim.0000237866.70357.c6","article-title":"Fabry disease: guidelines for the evaluation and management of multi-organ system involvement","volume":"8","author":"Eng","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.dld.2018.02.011_bib0130","doi-asserted-by":"crossref","first-page":"85895","DOI":"10.18632\/oncotarget.13135","article-title":"Genetic variants associated with gastrointestinal symptoms in Fabry disease","volume":"7","author":"Di Martino","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.dld.2018.02.011_bib0135","doi-asserted-by":"crossref","first-page":"61415","DOI":"10.18632\/oncotarget.18250","article-title":"Inter-familial and intra-familial phenotypic variability in three Sicilian families with Anderson\u2013Fabry disease","volume":"8","author":"Tuttolomondo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.dld.2018.02.011_bib0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2377-11-61","article-title":"Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel","volume":"11","author":"Burlina","year":"2011","journal-title":"BMC Neurol"},{"key":"10.1016\/j.dld.2018.02.011_bib0145","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejim.2016.03.015","article-title":"The impact of fever\/hyperthermia in the diagnosis of Fabry: a retrospective analysis","volume":"32","author":"Verrecchia","year":"2016","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.dld.2018.02.011_bib0150","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s11739-017-1704-y","article-title":"Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown origin","volume":"12","author":"Manna","year":"2017","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.dld.2018.02.011_bib0155","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1177\/1756283X16642936","article-title":"Understanding the gastrointestinal manifestations of Fabry disease: promoting prompt diagnosis","volume":"9","author":"Zar-Kessler","year":"2016","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.dld.2018.02.011_bib0160","series-title":"Fabry disease: perspectives from 5 years of FOS","article-title":"Gastrointestinal manifestations of Fabry disease","author":"Keshav","year":"2006"},{"key":"10.1016\/j.dld.2018.02.011_bib0165","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00006231-199809000-00009","article-title":"Gastrointestinal symptoms and delayed gastric emptying in Fabry's disease: response to metoclopramide","volume":"19","author":"Argoff","year":"1998","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.dld.2018.02.011_bib0170","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ymgmr.2017.03.004","article-title":"Chronic intestinal pseudo-obstruction. Did you search for lysosomal storage diseases?","volume":"11","author":"Politei","year":"2017","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.dld.2018.02.011_bib0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/8904_2011_63","article-title":"Gastrointestinal phenotype of Fabry disease in a patient with pseudoobstruction syndrome","volume":"4","author":"Buda","year":"2012","journal-title":"JIMD Rep"},{"key":"10.1016\/j.dld.2018.02.011_bib0180","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0016-5085(84)80028-1","article-title":"Jejunal diverticulosis with perforation as a complication of Fabry's disease","volume":"86","author":"Friedman","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2018.02.011_bib0185","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/pgmj.67.788.584","article-title":"Colonic involvement in Fabry's disease","volume":"67","author":"Jack","year":"1991","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.dld.2018.02.011_bib0190","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cge.12673","article-title":"Gastrointestinal involvement in Fabry disease. So important, yet often neglected","volume":"89","author":"Politei","year":"2016","journal-title":"Clin Genet"},{"key":"10.1016\/j.dld.2018.02.011_bib0195","series-title":"Fabry disease: perspectives from 5 years of FOS","article-title":"Neuropsychiatric and psychosocial aspects of Fabry disease","author":"M\u00fcller","year":"2006"},{"key":"10.1016\/j.dld.2018.02.011_bib0200","doi-asserted-by":"crossref","DOI":"10.1007\/8904_2017_21","article-title":"Treatment of depression in adults with Fabry disease","author":"Ali","year":"2017","journal-title":"JIMD Rep"},{"key":"10.1016\/j.dld.2018.02.011_bib0205","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10545-013-9643-x","article-title":"Cognitive dysfunction and depression in Fabry disease: a systematic review","volume":"37","author":"Bolsover","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.dld.2018.02.011_bib0210","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","article-title":"Modeling valuations for EuroQol health states","volume":"35","author":"Dolan","year":"1997","journal-title":"Med Care"},{"key":"10.1016\/j.dld.2018.02.011_bib0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2007.09.007","article-title":"Safety and efficacy of enzyme replacement therapy with agalsidase beta: an international, open-label study in pediatric patients with Fabry disease","volume":"152","author":"Wraith","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.dld.2018.02.011_bib0220","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0016-5085(82)80262-X","article-title":"Pathophysiologic and ultrastructural basis for intestinal symptoms in Fabry's disease","volume":"82","author":"O\u2019Brien","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2018.02.011_bib0225","first-page":"246","article-title":"Gastrointestinal structure and function in Fabry's disease","volume":"76","author":"Sheth","year":"1981","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2018.02.011_bib0230","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00005072-197903000-00001","article-title":"Autonomic neurons affected by lipid storage in the spinal cord in Fabry's disease: distribution of autonomic neurons in the sacral cord","volume":"38","author":"Sung","year":"1979","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.dld.2018.02.011_bib0235","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymgme.2009.10.004","article-title":"Vasculopathy in patients with Fabry disease: current controversies and research directions","volume":"99","author":"Rombach","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.dld.2018.02.011_bib0240","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/MEG.0b013e32800fef46","article-title":"A diagnosis of Fabry gastrointestinal disease by chance: a case report","volume":"19","author":"Feriozzi","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2018.02.011_bib0245","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10897-007-9128-x","article-title":"Diagnosis of Fabry disease via analysis of family history","volume":"17","author":"Laney","year":"2008","journal-title":"J Genet Couns"},{"key":"10.1016\/j.dld.2018.02.011_bib0250","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1097\/HJH.0b013e328336a077","article-title":"Enzyme replacement therapy improves cardiovascular responses to orthostatic challenge in Fabry patients","volume":"28","author":"Hilz","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.dld.2018.02.011_bib0255","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2377-10-38","article-title":"Autonomic neuropathy in Fabry disease: a prospective study using the Autonomic Symptom Profile and cardiovascular autonomic function tests","volume":"10","author":"Biegstraaten","year":"2010","journal-title":"BMC Neurol"},{"key":"10.1016\/j.dld.2018.02.011_bib0260","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jacc.2016.05.090","article-title":"Genetic screening of Anderson\u2013Fabry disease in probands referred from multispecialty clinics","volume":"68","author":"Favalli","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.dld.2018.02.011_bib0265","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01535722","article-title":"GSRS\u2014a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease","volume":"33","author":"Svedlund","year":"1988","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2018.02.011_bib0270","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13023-015-0253-6","article-title":"Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document","volume":"10","author":"Biegstraaten","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.dld.2018.02.011_bib0275","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.kint.2016.10.004","article-title":"Screening, diagnosis, and management of patients with Fabry disease: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"91","author":"Schiffmann","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.dld.2018.02.011_bib0280","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymgme.2015.10.007","article-title":"The management and treatment of children with Fabry disease: a United States-based perspective","volume":"117","author":"Hopkin","year":"2016","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.dld.2018.02.011_bib0285","unstructured":"Replagal Summary of Product Characteristics. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000369\/WC500053612.pdf [accessed 05.10.17]."},{"key":"10.1016\/j.dld.2018.02.011_bib0290","unstructured":"Fabrazyme Summary of Product Characteristics. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000370\/WC500020547.pdf [accessed 05.10.17]."},{"key":"10.1016\/j.dld.2018.02.011_bib0295","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1681\/ASN.2012030316","article-title":"Agalsidase benefits renal histology in young patients with Fabry disease","volume":"24","author":"T\u00f8ndel","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.dld.2018.02.011_bib0300","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1023\/B:BOLI.0000037342.59612.69","article-title":"Relief of gastrointestinal symptoms under enzyme replacement therapy in patients with Fabry disease","volume":"27","author":"Dehout","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.dld.2018.02.011_bib0305","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00228-007-0460-8","article-title":"Fabry disease and treatment with agalsidase alfa: unsuspected cardiac arrythmia in two heterozygous women. In reference to pharmacovigilance","volume":"64","author":"Mougenot","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.dld.2018.02.011_bib0310","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ymgme.2005.04.009","article-title":"Gastrointestinal manifestations of Fabry disease: clinical response to enzyme replacement therapy","volume":"85","author":"Banikazemi","year":"2005","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.dld.2018.02.011_bib0315","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00054725-200501000-00020","article-title":"Co-existence of Fabry disease and Crohn's disease: a case report","volume":"11","author":"Altarescu","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2018.02.011_bib0320","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1399-0004.2012.01947.x","article-title":"Fabry disease in children: agalsidase-beta enzyme replacement therapy","volume":"83","author":"Borgwardt","year":"2013","journal-title":"Clin Genet"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865818302093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865818302093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T18:33:12Z","timestamp":1668796392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865818302093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1590865818302093"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2018.02.011","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-specific gastrointestinal features: Could it be Fabry disease?","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2018.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}